Financials data is unavailable for this security.
View more
Year on year Proteomics International Laboratories Ltd 's revenues fell -4.24% from 1.47m to 1.41m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 6.18m to a larger loss of 6.38m.
| Gross margin | -- |
|---|---|
| Net profit margin | -459.82% |
| Operating margin | -457.63% |
| Return on assets | -61.88% |
|---|---|
| Return on equity | -71.67% |
| Return on investment | -67.65% |
More ▼
Cash flow in AUDView more
In 2024, Proteomics International Laboratories Ltd increased its cash reserves by 10.17%, or 612.92k. Cash Flow from Financing totalled 6.59m or 467.79% of revenues. In addition the company used 5.59m for operations while cash used for investing totalled 388.02k.
| Cash flow per share | -0.0457 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0719 |
|---|---|
| Tangible book value per share | 0.0719 |
More ▼
Balance sheet in AUDView more
| Current ratio | 10.13 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0336 |
|---|---|
| Total debt/total capital | 0.0331 |
More ▼
